Clinical trials for medicines: apply for authorisation in the UK
Approximately one third of the weight loss corresponded to lean mass reduction
Tan X, Liu Q, Fang Y, Yang S, Chen F, Wang J, et al
The discussion concludes with a sober look at what would need to change for peptides to become broadly usable therapies, where legitimate peptide therapeutics may expand next, and which areas of medicine stand to benefit most right now
For example: Low stomach acid: As we age or due to conditions like acid reflux, the bodys ability to absorb B12 from food or oral supplements diminishes
Reading Published Dose Ranges Correctly Retatrutides Phase 3 TRIUMPH-1 trial, with topline results reported by Eli Lilly in May 2026, evaluated three target doses 4mg, 9mg, and 12mg weekly with all arms starting at 2mg and escalating in steps every four weeks (2mg 4mg 6mg 9mg 12mg, depending on target arm) rather than starting at the target dose directly